evelopment of potential pharmaceutical
products, including the results of any clinical programs with respect to
TREANDA or the timing or approval of any current or future filings for
regulatory approval of TREANDA or other Cephalon compounds; interpretation
of clinical results, particularly with respect to the TREANDA clinical
trials; manufacturing development and capabilities; market prospects for
its products, including the anticipated availability of TREANDA in the
United States or the benefits TREANDA may provide; sales and earnings
guidance; and other statements regarding matters that are not historical
facts. You may identify some of these forward-looking statements by the use
of words in the statements such as "anticipate," "estimate," "expect,"
"project," "intend," "plan," "believe" or other words and terms of similar
meaning. Cephalon's performance and financial results could differ
materially from those reflected in these forward-looking statements due to
general financial, economic, regulatory and political conditions affecting
the biotechnology and pharmaceutical industries as well as more specific
risks and uncertainties facing Cephalon such as those set forth in its
reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and
Exchange Commission. Given these risks and uncertainties, any or all of
these forward-looking statements may prove to be incorrect. Therefore, you
should not rely on any such factors or forward-looking statements.
Furthermore, Cephalon does not intend to update publicly any
forward-looking statement, except as required by law. The Private
Securities Litigation Reform Act of 1995 permits this discussion.
'/>"/>SOURCE Cephalon, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
Video: Nutrition Comes to NASCAR2.
Video: Circulatory Care of New Jersey3.
Video: GEN Video Hits Home with Web Audience4.
Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event5.
Video: Food Expert B. Smith to Provide Healthy Menu Makeovers6.
Video: New FDA-Approved Sun Protectant Saves Skin All Year Round7.
Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk8.
Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure9.
Video: Holiday Safety Is Important10.
Video: Grin Big With an Award-Winning Smile11.
Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study